Chagas Disease clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • LXE408 in Participants With Chronic Chagas Disease.

    open to eligible people ages 18-60

    This study is to investigate the ability of LXE408 to reduce or remove the level of parasites in the blood of people with chronic Chagas disease. Participants must have chronic Chagas disease without severe organ dysfunction.

    Sylmar 5400784, California 5332921 and other locations

Our lead scientists for Chagas Disease research studies include .

Last updated: